{
    "2021-11-03": [
        [
            {
                "time": "",
                "original_text": "高瓴资本三季度减仓：不确定性增加成新常态，安全边际与成长性需要重新定位",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "减仓",
                        "不确定性",
                        "安全边际",
                        "成长性"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
                "features": {
                    "keywords": [
                        "公募基金",
                        "持股市值",
                        "创新高",
                        "社保",
                        "加仓",
                        "周期股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "周期股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物上市公司2021年三季报小结：板块业绩增速继续稳定 自下而上寻找专精特新",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "业绩增速",
                        "稳定",
                        "专精特新"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}